EPM2A Antibody | 46-781

EPM2A Antibody | 46-781 | Gentaur UK, US & Europe Distribution

Host: Goat

Reactivity: Human

Homology: Expected Species Reactivity based on sequence homology: Mouse, Rat, Dog, Cow

Immunogen: The immunogen for this antibody is: C-EATGHTNEMKHTTD

Research Area: Homeostasis, Neuroscience

Tested Application: E, WB, IHC

Application: Peptide ELISA: antibody detection limit dilution 1:16000.Western Blot:Approx. 38kDa band observed in Human Brain (Cerebellum) lysates (calculated MW of 37.2kDa according to NP_005661.1) . Recommended concentration: 0.1-0.3ug/ml. Primary incubation was 1 hour.Immunohistochemistry:Paraffin embedded Human Brain (Cerebellum) and Heart. Recommended concentration: 2.5ug/ml.

Specificiy: This antibody is expected to recognize isoform a (NP_005661.1) only.

Positive Control 1: Cat. No. 1362 - Human Cerebellum, Left Lysate
Cat. No. 1363 - Human Cerebellum, Right Lysate

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: N/A

Validation: N/A

Isoform: N/A

Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Clonality: Polyclonal

Clone: N/A

Isotype: N/A

Conjugate: Unconjugated

Physical State: Liquid

Buffer: Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. Aliquot and store at -20°C. Minimize freezing and thawing.

Concentration: 500 ug/mL

Storage Condition: Aliquot and store at -20˚C. Minimize freezing and thawing.

Alternate Name: epilepsy, progressive myoclonus type 2, Lafora disease (laforin) , laforin, EPM2A, epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) , EPM2, MELF

User Note: N/A

BACKGROUND: N/A